Proton-beam radiotherapy for early-stage lung cancer

Chest

Volumn 116, Issue 5, 1999, Pages 1313-1319

  Bush, David A ^a   Slater, Jerry D ^a   Bonnet, Reiner ^c   Cheek, Gregory A ^b   Dunbar, Richard D ^b   Moyers, Michael ^a   Slater, James M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c Bad Berka GmbH   (Germany)

Author keywords

Inoperable; Lung cancer; Proton; Radiotherapy

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RADIATION RESPONSE; SURVIVAL RATE;

EID: 0032698686     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.5.1313     Document Type: Article

References (22)

1. 1 Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998 [published erratum appears in CA Cancer J Clin 1998; 48(3):192]. CA Cancer J Clin 1998; 48:6-29
2. 1 Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998 [published erratum appears in CA Cancer J Clin 1998; 48(3):192]. CA Cancer J Clin 1998; 48:6-29
3. 2 Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717
4. 3 Harpole DH Jr, Herndon JE 2nd, Young WG Jr, et al. Stage I nonsmall cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995; 76:787-796
5. 4 Sibley G, Jamieson T, Marks L, et al. Dose escalation without elective nodal irradiation is indicated in stage I nonsmall cell lung cancer [abstract]. Int J Radiat Oncol Biol Phys 1996; 36:348
6. 5 Krol AD, Aussems P, Noordijk EM, et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996; 34:297-302
7. 6 Sandler HM, Curran WJ Jr, Turrisi AT 3rd. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1990; 19:9-13
8. 7 Dosoretz DE, Katin MJ, Blitzer PH, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992; 24:3-9
9. 8 Kaskowitz L, Graham MV, Emami B, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27:517-523
10. 9 Suit HD, Goitein M, Tepper J, et al. Exploratory study of proton radiation therapy using large field techniques and fractionated dose schedules. Cancer 1975; 35:1646-1657
11. 10 Archambeau JO, Slater JD, Coutrakon G, et al. Proton-beam irradiation for the cancer patient: an approach to optimal therapy and normal tissue-sparing. In: John L, ed. Advances in radiation biology. San Diego, CA: Academic Press, 1994; 53-89
12. 11 Urano M, Verhey LJ, Goitein M, et al. Relative biological effectiveness of modulated proton beams in various murine tissues. Int J Radiat Oncol Biol Phys 1984; 10:509-514
13. 12 Bush DA, Dunbar RD, Bonnet R, et al. Pulmonary injury from proton-beam and conventional radiotherapy, as revealed by chest CT. AJR Am J Roentgenol 1998; 172:735-774
14. 13 Archambeau JO, Bennett GW, Levine GS, et al. Proton radiation therapy. Radiology 1974; 110:445-457
15. 14 Wilson R. Radiological use of fast protons. Radiology 1946; 47:487-491
16. 15 Slater JM, Archambeau JO, Miller DW, et al. The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development. Int J Radiat Oncol Biol Phys 1992; 22:383-389
17. 16 Cox JD, Byhardt RW, Wilson JF, et al. Complications of radiation therapy and factors in their prevention. World J Surg 1986; 10:171-188
18. 17 Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62:679-694
19. 18 Wilson GD, McNally NJ, Dische S, et al. Measurement of cell kinetics in human tumors in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988; 58:423-431
20. 19 Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27:131-146
21. 20 Saunders M, Dische S, Barrett A, et al. Continuous hyper-fractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multicenter trial - CHART Steering Committee. Lancet 1997; 350:161-165
22. 21 Hall EJ. Radiobiology for the radiologist. 4th ed. Philadelphia, PA: Lippincott, 1994; 223-227